Coalition to Cure Calpain 3 (C3) will award Travel Grants to foster early career investigators who are currently conducting preclinical or clinical research in the area of calpainopathy (also known as Limb Girdle Muscular Dystrophy Type 2A or LGMD2A). The
Coalition to Cure Calpain 3 (C3) is proud to support September 30 “Limb Girdle MD Awareness Day” with the announcement that we are awarding a new research grant to Dr. Michele Calos, Professor in the Department of Genetics at Stanford
Limb Girdle Muscular Dystrophy Awareness Day is an annual collaborative effort to globally raise awareness of individuals living with Limb Girdle Muscular Dystrophy (LGMD) and is held on September 30th. The third annual global “Limb Girdle Muscular Dystrophy Awareness Day” will
Stem cells are cells that have the unique ability to self-renew and to transform into many specialized cell types. They can be isolated either from embryos or from adult tissue. Adult stem cells are being used for various medical therapies
Coalition to Cure Calpain 3 (C3) is excited to announce that we are funding a new research project with Dr. Rita Perlingeiro, Professor of Medicine and Lillehei Professor in Stem Cell and Regenerative Cardiovascular Medicine at the University of Minnesota.
Key leaders from pharma, academia, and the nonprofit sector convened in Iowa City, Iowa for the Muscle Membrane Serendipity: Past, Present and Future conference on July 20-22, 2017. The invitation-only conference was organized by C3 Scientific Advisory Board member Dr.
Clinical studies and trials involve research using human volunteers (also called participants) that is intended to add to medical knowledge. Developing new medicines and treatments is a lengthy and complex process, relying heavily on volunteer participation to help with better
Rare disease patients, caregivers, representatives from advocacy organizations, and other rare disease stakeholders met on May 19, 2017 in Philadelphia for the 2017 RARE Patient Advocacy Symposium, a partnership of Global Genes and the Penn Medicine Orphan Disease Center. The
Coalition to Cure Calpain 3 (C3) is excited to announce that we are funding a new research project with Dr. Melissa Spencer at the University of California Los Angeles. The project is titled “Identification of calpain 3 substrates through use
The C3 RFA that was announced on September 15, 2016 is drawing to a close, and we request that all submissions, which we have been receiving on a rolling basis, be sent to Dr. Jennifer Levy no later than June